Physician profile
Constance M Flynn
NPI 1508120445
$2,138.16
in general payments reported to CMS, 2019-2025
19 companies · $800 in 2025
The $800 reported for 2025 was more than what 88% of Community Health (Nurse Practitioner) providers received nationally (typical 2025 total: $139).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $103 · 2023: $531 · 2024: $580 · 2025: $800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,910.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $245.40 | 2022-2024 | Spravato |
| Cequr Corporation | $150.00 | 2024 | Cequr Simplicity |
| Madrigal Pharmaceuticals | $148.03 | 2025 | Rezdiffra |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2021 | |
| Kyowa Kirin, INC. | $124.99 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2025 | Jardiance |
| Axsome Therapeutics, INC. | $123.19 | 2023 | Sunosi |
| Abbvie INC. | $121.92 | 2023 | |
| Gilead Sciences, INC. | $112.26 | 2023 | Epclusa |
| Alexion Pharmaceuticals, INC. | $108.40 | 2024 | Strensiq |
| Abiomed | $103.84 | 2025 | |
| Lilly USA, LLC | $102.82 | 2025 | Zepbound |
| Calliditas Therapeutics US INC. | $98.56 | 2025 | Tarpeyo |
| Sanofi-Aventis U.S. LLC | $96.51 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $95.00 | 2024 | Austedo Xr |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $89.64 | 2023 | |
| Sage Therapeutics, LLC | $83.54 | 2023 | |
| Viiv Healthcare Company | $64.37 | 2024 | Apretude |
| Indivior INC. | $19.70 | 2024 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constance Flynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.